Healthcare & Life Sciences Industry Updates

Google News – Medical Devices External News

Faster medical device approvals need stronger regulation - Deccan Herald

news.google.com · 10 Jul 2026

Google News – Medical Devices External News

Stryker Corp. focuses on innovation as medical device demand grows - Ad-hoc-news.de

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B - AJMC

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials - Stocktwits

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Accelerating and Modernizing Early and Late-Stage Clinical Development - fda.gov

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

FDA to launch pilot program to speed up early-stage clinical trials - STAT

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire

news.google.com · 10 Jul 2026

Google News – Clinical Trials External News

Eli Lilly’s Ebglyss wins Canadian drug approval for eczema - eciks.org

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

S&P 500 Futures Climb In Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead - Moomoo

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

H.C. Wainwright reiterates Vanda Pharmaceuticals stock rating on FDA designation - Investing.com

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals (RYTM) On TRANSCEND And New Approvals, Buying Opportunity Or Priced In? - simplywall.st

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters

news.google.com · 10 Jul 2026

Google News – Pharmaceuticals External News

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Yahoo! Finance Canada

news.google.com · 10 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Faster medical device approvals need stronger regulation - Deccan Herald

Stryker Corp. focuses on innovation as medical device demand grows - Ad-hoc-news.de

Upcoming 2026 FDA Decisions Could Expand Treatment Options Across Oncology and Hepatitis B - AJMC

FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials - Stocktwits

Accelerating and Modernizing Early and Late-Stage Clinical Development - fda.gov

FDA to launch pilot program to speed up early-stage clinical trials - STAT

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - GlobeNewswire

Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate - GlobeNewswire

Eli Lilly’s Ebglyss wins Canadian drug approval for eczema - eciks.org

S&P 500 Futures Climb In Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead - Moomoo

H.C. Wainwright reiterates Vanda Pharmaceuticals stock rating on FDA designation - Investing.com

Rare skin disease gets first company-backed clinical trial as Quoin wins FDA clearance - Stock Titan

Rhythm Pharmaceuticals (RYTM) On TRANSCEND And New Approvals, Buying Opportunity Or Priced In? - simplywall.st

India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome - Yahoo! Finance Canada